Resources
Show All Related Tags
Did you mean
cell phone (2,891 results), cell (2,086 results), stem-cell (1,079 results), fuel cell (870 results), hydrogen fuel cell (35 results)more...
Show Fewer Related Tags
Did you mean
cell phone (2,891 results), cell (2,086 results), stem-cell (1,079 results), fuel cell (870 results), hydrogen fuel cell (35 results), Cell Therapeutics Inc. (14 results), Cell Genesys Inc. (11 results), cell phone carrier (6 results), cell phone company (3 results), Millennium Cell Inc. (3 results), Pacific Fuel Cell Corp. (3 results), Sodra Cell AB (3 results), cell phone chip (2 results), Cryo-Cell International Inc. (2 results), cell phone virus (1 results), Cell Robotics International Inc. (1 results), Cell Tech International Inc., Cell Wireless Corp., Stem Cell Innovations Inc., Stem Cell Therapy International Inc.fewer...
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- MIT Researchers Report Results of Use of BioForce Nanosciences' Nano eNabler Molecular Printer
- BioForce Nanosciences Holdings, Inc. (OTCBB: BFNH), a leader in systems integration at the micro and nano scales to create products for the life sciences, is pleased to announce that researchers at the Massachusetts Institute of Technology ("MIT") have published their latest work with the Nano eNablerTM molecular printer in the...
- Research articles 2008-10-28
- Cell Genesys Announces Receipt of Nasdaq Staff Deficiency Notice Relating to Non-Compliance With a Nasdaq Stock Market Listing Requirement
- SOUTH SAN FRANCISCO, Calif. -- Cell Genesys, Inc. (Nasdaq:CEGE) today announced that it has received a letter from The Nasdaq Stock Market dated October 21, 2008, indicating that the Company had become non-compliant with the minimum $1.00 bid price requirement for continued listing on The Nasdaq Global Market as set...
- Research articles 2008-10-22
- Innovative Silicon Unveils Z-RAM Memory Technology Breakthroughs at 2008 IEEE International SOI Conference
- Smallest Silicon Dynamic Memory Devices Ever Reported Largest Programming Window, Significantly Improved Retention Time Demonstrated NEW PALTZ, N.Y. -- Innovative Silicon, Inc. ISi, developer of the Z-RAM[R] zero-capacitor floating body memory technology, demonstrated here that its Z-RAM memory technology continues to show considerable advantages over DRAM implementations and...
- Research articles 2008-10-09
- CaridianBCT Initiates Clinical Trial for Whole Blood Process with Mirasol® Pathogen Reduction Technology
- Clinical Study is the Next Phase in the Development of a Transportable Pathogen Reduction and Blood Safety System for Treating Whole Blood LAKEWOOD, Colo. -- CaridianBCT, a leading global provider of technology, products and services in automated blood collections, therapeutic systems, whole blood processes and pathogen reduction technologies, announced...
- Research articles 2008-10-05
- HepaLife™ Announces Expansion of Exclusive License Agreement with U.S. Government Agency for Liver Cell Line
- HepaLife's expanded agreement with US Department of Agriculture allows for use of patented PICM-19 liver stem cell line as a malaria infection host system, in addition to artificial liver devices and in-vitro toxicological testing platforms. BOSTON -- HepaLife Technologies, Inc. (OTCBB: HPLF) (FWB: HL1) (WKN: 500625) today announced that...
- Research articles 2008-10-01
- Clarient Enters into Training and Consulting Agreement with University of Pennsylvania School of Medicine
- ALISO VIEJO, Calif. -- Clarient, Inc. (NASDAQ:CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, announced today that it has entered into an agreement with the University of Pennsylvania School of Medicine's Flow Cytometry and Cell Sorting Resource Laboratory Flow Cytometry Lab...
- Research articles 2008-09-29
- Dosing Initiated in TransMolecular's Phase 1/2 Clinical Trial for Intravenous Administration of Iodine-TM601 in Patients with Recurrent Malignant Glioma
- -First patient treated at University of Chicago Medical Center- CAMBRIDGE, Mass. -- TransMolecular, Inc., a biotechnology company focused on targeted therapies for cancer, announced today that dosing was initiated in a Phase 1/2 trial of 131I-TM601 delivered intravenously IV for the treatment of adult patients with recurrent malignant glioma....
- Research articles 2008-09-29
- U.S. District Court, Western District of New York Case Summaries:
- Prisoner Civil Rights George v. McGinnis 05-CV-84 Judge Schroeder Background: The plaintiff commenced the suit pursuant to 42 U.S.C. [section]1983 alleging that, during his incarceration at the Southport Correctional Facility, he was deprived of rights pursuant to the Eighth...
- Research articles 2008-09-25
- Pluristem Therapeutics Announces US$1 Million Sale of Shares at 44% Premium to Market Price
- NEW YORK -- Pluristem Therapeutics Inc. (NasdaqCM:PSTI) (DAX:PJT) a bio-therapeutics company dedicated to the commercialization of non-personalized allogeneic cell therapy products for a variety of degenerative, ischemic and autoimmune indications, today announced it has entered into definitive agreements to sell common stock and warrants for aggregate gross proceeds of $1,035,000....
- Research articles 2008-09-23
- Creative Thinking Nets Stanford Researchers Two NIH Pioneer Awards, Three New Innovator Awards
- STANFORD, Calif. -- Two scientists at the Stanford University School of Medicine who've sussed out ways to see what's usually hidden are winners of this year's NIH Director's Pioneer Awards--the National Institutes of Health's most prestigious award for creative thinkers. Secrets held within a living being's brain and a...
- Research articles 2008-09-22
- Nanobiotix Announces Issue of European Patent Protecting Its nanoXray™ Anticancer Platform
- PARIS -- Nanobiotix, an emerging nanomedicine company focused on cancer therapy, announced today that the European Patent Office EPO has issued Patent No. 1744789 to the Company, related to its "novel activable particles that can be used in the health sector." More specifically, the patent protects "composite particles that...
- Research articles 2008-09-22
- World Renowned ALS Expert From Harvard Medical School and Mass. General Hospital, Dr. Robert H. Brown Jr., Joins BrainStorm Cell Therapeutics Scientific Advisory Board
- NEW YORK & PETACH TIKVAH, Israel -- Brainstorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that world renowned ALS medical expert, Dr. Robert H. Brown, Jr., MD, PhD from Harvard Medical School and Massachusetts General Hospital MGH, has joined the Company's...
- Research articles 2008-09-02
- Cracking enzyme code opens way to new cancer drugs
- PARIS AFP — Researchers have broken the code of an enzyme that plays a key role in the growth of most cancers, opening a path that potentially leads to a new class of anti-cancer drugs, according to a study released Sunday. Other scientists who reviewed the study hailed it...
- Research articles 2008-08-31
- World first: Lasers used in keyhole surgery for brain cancer
- PARIS AFP — In a ground-breaking advance, French neurosurgeons on Friday said they had successfully treated brain tumours through ultra-keyhole surgery, using a tiny fibre-optic laser to destroy cancerous cells. Alexandre Carpentier of the Pitie-Salpetriere Hospital in Paris said the exploit was "a world-first" in its use of multiple...
- Research articles 2008-08-29
- Arab-Israeli accused of seeking to create Qaeda cell
- JERUSALEM AFP — An Arab-Israeli was charged on Friday with trying to contact Al-Qaeda in a bid to set up a local cell of the global extremist network, police said. The indictment alleges that Khaled Abu Raqiq, 24, a Bedouin from the southern town of Tel Sheva, used the...
- Research articles 2008-08-22
- Regulus Therapeutics and Collaborators Publish New Data on a Critical Role for miR-21 in Brain Tumors
- CAMBRIDGE, Mass. & CARLSBAD, Calif. -- Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover, develop, and commercialize microRNA-based therapeutics, announced today the publication of new research in the journal Molecular and Cellular Biology on the role of...
- Research articles 2008-08-19
- Yemen says Qaeda cell broken amid new crackdown
- SANAA AFP — Yemen has uncovered a new "terrorist" cell as security forces step up their hunt for suspected Al-Qaeda militants in the eastern province of Hadramaut, security officials said on Friday. Security forces detained one Qaeda suspect from the cell that operated near the port city of Al-Mukalla...
- Research articles 2008-08-15
- They say
- "There is not a cell in my body that can accept the idea that Mr Obama can keep us safe from the terrorists around the world" - Actor Jon Voight on the Democrat White House hopeful. "When we rehearsed taking our clothes off, we were all very careful. We...
- Research articles 2008-08-14
- Helicos and Uppsala University Collaborate to Study Genome Structure and Its Effects on Gene Expression Utilizing True Single Molecule Sequencing Technology
- CAMBRIDGE, Mass. -- Helicos BioSciences Corporation (NASDAQ:HLCS) today announced a scientific collaboration with a respected genomics research group at Sweden's Uppsala University aimed at gaining new insights into how genome structure plays a key role in the ways genes are regulated within cells. The Uppsala team, led by Claes...
- Research articles 2008-08-05
- Two Stanford Faculty Will Benefit from Keck Awards
- STANFORD, Calif. -- Stanford University has received two million-dollar grants from the W.M. Keck Foundation for projects aimed at using light to control a variety of cells and exploring how specific enzymes help embryonic stem cells turn into adult cells. The beneficiaries of the grants are Karl Deisseroth, MD, PhD,...
- Research articles 2008-08-04
- << Previous
- page 1 of 105
- Next >>
Content Types
Refining Tags
- Hardware (175 results)
- Agence France-Presse (162 results)
- Patient (136 results)
- Company (132 results)
- Stem-cell (129 results)
- Semiconductors (115 results)
- Nasdaq Stock Market Inc. (113 results)
- Finance (112 results)
- Components (104 results)
- researcher (98 results)
- Processors (94 results)
- SECURITY (90 results)
- Protein (89 results)
- Government (89 results)
- Healthcare (85 results)
- Biology (78 results)
- Biotechnology (75 results)
- patent (75 results)
- Yale University (74 results)
- Molecular Inc. (73 results)
- Software (72 results)
- Therapy (68 results)
- scientist (67 results)
- stock (66 results)
- Dr. (64 results)
- Manufacturing (62 results)
- Investment (54 results)
- FDA (47 results)
- attack (46 results)
- Mice (44 results)
- Gene (42 results)
- Marketing (41 results)
- U.S. Congress (41 results)
- Mouse (41 results)
- Team (40 results)
- Phone (40 results)
- al-Qaeda (39 results)
- U.S. Department of Health and Human Services (39 results)
- Analysis (37 results)
- Business Wire (36 results)
- Network (35 results)
- Networking (35 results)
- Massachusetts Institute of Technology (35 results)
- vaccine (35 results)
- embryo (35 results)
- NASA (34 results)
- U.S. (34 results)
- DNA (34 results)
- M. (34 results)
- wireless (33 results)
